Contact PR

To use this feature, join Babbler easily !

arrow_back

is a free tool for journalists
Do not suffer news anymore, control it


By signing up you will be able to contact hundreds of press officer :
Caroline Grangie
Leboncoin
Media relation manager
Manon Guignard
Uber
Communication Associate
Sheherazade Renoux
PMU
Communication Manager

To learn more, watch the video

You're 1 click away from signing up
What is Babbler!

Previous

Nice to see you again !

Press release

SOTAGLIFLOZIN
timer minutes reading time minute reading time

Copy link
CURRENTLY IN REGULATORY REVIEW IN THE EU AND U.S. FOR USE AS AN ADJUNCT TO INSULIN THERAPY TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 1 DIABETES
sotagliflozin

Click to get original image size

Sotagliflozin is the first investigational, oral SGLT-1/2 dual inhibitor in clinical development for Type 1 Diabetes (T1D)

  • Health & Medicine
  • Medicine
  • Men's Health
  • Women's Health
inscrit avec succès

Congratulations, you're registered on Babbler!

Discover now all the news waiting for you on Babbler: visit your newsfeed.!

Your topics have been selected, you can change it by clicking here

  • Health & Medicine
  • Medicine
  • Men's Health